• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病(COPD)显著增加高血压患者发生脑血管和心血管事件的风险。

COPD significantly increases cerebral and cardiovascular events in hypertensives.

作者信息

Perticone Maria, Maio Raffaele, Caroleo Benedetto, Suraci Edoardo, Corrao Salvatore, Sesti Giorgio, Perticone Francesco

机构信息

Department of Medical and Surgical Sciences, University Magna Græcia, Viale Europa-Loc. Germaneto, 88100, Catanzaro, Italy.

Azienda Ospedaliero-Universitaria Mater Domini, Catanzaro, Italy.

出版信息

Sci Rep. 2021 Apr 12;11(1):7884. doi: 10.1038/s41598-021-86963-z.

DOI:10.1038/s41598-021-86963-z
PMID:33846434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8042020/
Abstract

Essential hypertension and chronic obstructive pulmonary disease often coexist in the same patient. The aim of this study was to evaluate whether the addition of chronic obstructive pulmonary disease modifies the risk of cardiovascular events in hypertensives. We enrolled 1728 hypertensives. Study outcomes included fatal and non-fatal cardiovascular stroke and myocardial infarction, and cardiovascular death. During a mean follow-up of 57 months there were 205 major adverse cardiovascular events (2.47 per 100 pts/yr): cardiac (n117; 1.41 per 100 pts/yr) and cerebrovascular (n = 77; 0.93 per 100 pts/yr). In hypertensives with chronic obstructive pulmonary disease we observed a greater number of cardiovascular events than in hypertensives without respiratory disease (133 [5.55 per 100 pts/yr) vs 72 [1.22 per 100 pts/yr], respectively. The addition of chronic obstructive pulmonary disease to hypertension increased the incidence of total and non-fatal stroke of more than nine- (2.42 vs 0.32 per 100 pts/yr) and 11-fold (2.09 vs 0.22 per 100 pts/yr), respectively. The same trend was observed for total (2.88 vs 0.81 per 100 pts/yr) and non-fatal (2.67 vs 0.79 per 100 pts/y) myocardial infarction. The presence of chronic obstructive pulmonary disease in hypertensives significantly increases the risk of stroke, myocardial infarction and major adverse cardiovascular events.

摘要

原发性高血压和慢性阻塞性肺疾病常并存于同一患者。本研究的目的是评估合并慢性阻塞性肺疾病是否会改变高血压患者发生心血管事件的风险。我们纳入了1728例高血压患者。研究结局包括致命和非致命性心血管卒中、心肌梗死以及心血管死亡。在平均57个月的随访期间,共发生205例主要不良心血管事件(每100例患者每年2.47例):心脏事件(n = 117;每100例患者每年1.41例)和脑血管事件(n = 77;每100例患者每年0.93例)。在合并慢性阻塞性肺疾病的高血压患者中,我们观察到的心血管事件数量多于无呼吸系统疾病的高血压患者(分别为133例[每100例患者每年5.55例]和72例[每100例患者每年1.22例])。高血压合并慢性阻塞性肺疾病使总卒中及非致命性卒中的发生率分别增加了9倍多(每100例患者每年2.42例 vs 0.32例)和11倍(每100例患者每年2.09例 vs 0.22例)。总心肌梗死(每100例患者每年2.88例 vs 0.81例)和非致命性心肌梗死(每100例患者每年2.67例 vs 0.79例)也观察到同样的趋势。高血压患者合并慢性阻塞性肺疾病会显著增加卒中、心肌梗死和主要不良心血管事件的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d694/8042020/f10ea771c16b/41598_2021_86963_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d694/8042020/345f7e2c40c7/41598_2021_86963_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d694/8042020/f10ea771c16b/41598_2021_86963_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d694/8042020/345f7e2c40c7/41598_2021_86963_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d694/8042020/f10ea771c16b/41598_2021_86963_Fig2_HTML.jpg

相似文献

1
COPD significantly increases cerebral and cardiovascular events in hypertensives.慢性阻塞性肺疾病(COPD)显著增加高血压患者发生脑血管和心血管事件的风险。
Sci Rep. 2021 Apr 12;11(1):7884. doi: 10.1038/s41598-021-86963-z.
2
Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study.心房颤动患者慢性阻塞性肺疾病的临床特征及预后意义:一项多中心心房颤动注册研究的结果
J Am Med Dir Assoc. 2014 Aug;15(8):576-81. doi: 10.1016/j.jamda.2014.04.009. Epub 2014 Jun 2.
3
[Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].[重度外周动脉疾病患者慢性阻塞性肺疾病的诊断患病率及困难]
Pol Merkur Lekarski. 2009 Aug;27(158):92-6.
4
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.非瓣膜性心房颤动合并慢性阻塞性肺疾病患者的主要不良心血管事件:ARAPACIS 研究。
Intern Emerg Med. 2018 Aug;13(5):651-660. doi: 10.1007/s11739-018-1835-9. Epub 2018 Mar 26.
5
Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).慢性阻塞性肺疾病是心肌梗死患者死亡的独立预测因素,但不是动脉粥样硬化事件的预测因素:缬沙坦急性心肌梗死试验(VALIANT)分析。
Eur J Heart Fail. 2009 Mar;11(3):292-8. doi: 10.1093/eurjhf/hfp001. Epub 2009 Jan 27.
6
Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD.COPD 急性加重后发生主要不良心脏事件的风险增加。
Respirology. 2019 Dec;24(12):1183-1190. doi: 10.1111/resp.13620. Epub 2019 Jun 21.
7
Pulmonary embolism in chronic obstructive pulmonary disease: a population-based cohort study.慢性阻塞性肺疾病中的肺栓塞:一项基于人群的队列研究。
COPD. 2014 Aug;11(4):438-43. doi: 10.3109/15412555.2013.813927.
8
Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.慢性阻塞性肺疾病对心房颤动预后的影响:欧洲观察性研究计划心房颤动试点调查(EORP-AF)总登记处的报告
Am Heart J. 2016 Nov;181:83-91. doi: 10.1016/j.ahj.2016.08.011. Epub 2016 Aug 27.
9
CHA2DS2-VASc scores predict major adverse cardiovascular events in patients with chronic obstructive pulmonary disease.CHA2DS2-VASc评分可预测慢性阻塞性肺疾病患者的主要不良心血管事件。
Clin Respir J. 2018 Mar;12(3):1038-1045. doi: 10.1111/crj.12624. Epub 2017 Mar 29.
10
Cardiovascular Outcomes and All-Cause Mortality in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (Overlap Syndrome).阻塞性睡眠呼吸暂停和慢性阻塞性肺疾病(重叠综合征)患者的心血管结局和全因死亡率。
Ann Am Thorac Soc. 2019 Jan;16(1):71-81. doi: 10.1513/AnnalsATS.201802-136OC.

引用本文的文献

1
Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study.慢性阻塞性肺疾病加重增加后续心血管事件风险:COPDGene 研究的纵向分析。
J Am Heart Assoc. 2024 Jun 4;13(11):e033882. doi: 10.1161/JAHA.123.033882. Epub 2024 May 31.
2
The association between diet quality and chronic obstructive pulmonary disease: a case-control study.饮食质量与慢性阻塞性肺疾病的相关性:病例对照研究。
BMC Public Health. 2023 Oct 23;23(1):2071. doi: 10.1186/s12889-023-16586-8.
3
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide.

本文引用的文献

1
Cardiovascular Comorbidities in Chronic Obstructive Pulmonary Disease (COPD)-Current Considerations for Clinical Practice.慢性阻塞性肺疾病(COPD)中的心血管合并症——临床实践的当前考量
J Clin Med. 2019 Jan 10;8(1):69. doi: 10.3390/jcm8010069.
2
Cardiovascular disease and COPD: dangerous liaisons?心血管疾病与 COPD:危险的联姻?
Eur Respir Rev. 2018 Oct 3;27(149). doi: 10.1183/16000617.0057-2018. Print 2018 Sep 30.
3
Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study.
COPD 相关肺动脉高压的新兴表型:实用指南。
Curr Opin Pulm Med. 2022 Sep 1;28(5):343-351. doi: 10.1097/MCP.0000000000000890. Epub 2022 Jul 16.
4
The impact of diabetes and osteoarthritis on the occurrence of stroke, acute myocardial infarction, and heart failure among older adults with non-valvular atrial fibrillation in Hawaii: a retrospective observational cohort study.夏威夷非瓣膜性心房颤动老年患者中糖尿病和骨关节炎对中风、急性心肌梗死及心力衰竭发生情况的影响:一项回顾性观察队列研究
BMC Public Health. 2021 Jun 21;21(1):1183. doi: 10.1186/s12889-021-11247-0.
白蛋白尿、肺功能下降与新发慢性阻塞性肺疾病风险:美国国立卫生研究院心肺血液研究所队列研究
Am J Respir Crit Care Med. 2019 Feb 1;199(3):321-332. doi: 10.1164/rccm.201803-0402OC.
4
2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南:欧洲心脏病学会动脉高血压管理特别工作组和欧洲高血压学会:欧洲心脏病学会动脉高血压管理特别工作组和欧洲高血压学会。
J Hypertens. 2018 Oct;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940.
5
Competitive interaction between chronic obstructive pulmonary disease and CHADS-VASc score in predicting incident atrial fibrillation.慢性阻塞性肺疾病与 CHADS-VASc 评分在预测新发心房颤动中的竞争作用。
Int J Cardiol. 2018 Mar 15;255:74-79. doi: 10.1016/j.ijcard.2017.11.036. Epub 2017 Nov 20.
6
Microalbuminuria predicts the recurrence of cardiovascular events in patients with essential hypertension.
J Hypertens. 2016 Apr;34(4):646-53. doi: 10.1097/HJH.0000000000000846.
7
Chronic obstructive pulmonary disease comorbidities.慢性阻塞性肺疾病的合并症
Curr Opin Pulm Med. 2016 Mar;22(2):113-8. doi: 10.1097/MCP.0000000000000241.
8
Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study.慢性阻塞性肺疾病与中风风险。鹿特丹研究。
Am J Respir Crit Care Med. 2016 Feb 1;193(3):251-8. doi: 10.1164/rccm.201505-0962OC.
9
Prevalence of chronic obstructive pulmonary disease among patients with systemic arterial hypertension without respiratory symptoms.无呼吸道症状的系统性动脉高血压患者中慢性阻塞性肺疾病的患病率
Int J Chron Obstruct Pulmon Dis. 2015 Jul 31;10:1525-9. doi: 10.2147/COPD.S85588. eCollection 2015.
10
Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies.初级保健中多种疾病的患病率、决定因素及模式:观察性研究的系统评价
PLoS One. 2014 Jul 21;9(7):e102149. doi: 10.1371/journal.pone.0102149. eCollection 2014.